Bide Pharmatech Co Stock

Bide Pharmatech Co P/B

The P/B (Price-to-Book Ratio) of Bide Pharmatech Co (688073.SS) as of Aug 26, 2026 is 2.66. In the previous year, P/B (Price-to-Book Ratio) was 2.58 — a change of 3.11% (higher).

P/B

2.66

YoY

3.11%

Last updated:

P/B (Price-to-Book Ratio) of Bide Pharmatech Co is 2026 2.66 . P/B (Price-to-Book Ratio) of Bide Pharmatech Co was 2025 2.58 . It decreases by 3.11% higher compared to the previous year.

The Bide Pharmatech Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2019
39.55 CNY
Jan 1, 2020
14.79 CNY
Jan 1, 2021
8.57 CNY
Jan 1, 2022
2.59 CNY
Jan 1, 2023
2.58 CNY
Jan 1, 2024
2.66 CNY
The Bide Pharmatech Co P/B history
YEARP/BYoY
2.66+3.11%
2.58-0.66%
2.59-69.71%
8.57-42.08%
14.79-62.61%
39.55
Access this data via the Eulerpool API

Bide Pharmatech Co Stock analysis

What does Bide Pharmatech Co do? Bide Pharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bide Pharmatech Co stock

P/B (Price-to-Book Ratio) of Bide Pharmatech Co is 2.66 in 2026.

P/B (Price-to-Book Ratio) of Bide Pharmatech Co changed from 2.58 to 2.66, representing a 3.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Bide Pharmatech Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Bide Pharmatech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Bide Pharmatech Co

All Key Metrics — Bide Pharmatech Co